一种新的预后模型,用于预测在重症监护室急性至慢性肝衰竭患者的死亡率
Shih-Hua Lin1, Wei-Ting Chen2,3, Ming-Hung Tsai2,3
1Department of Gastroenterology and Hepatology, New Taipei Municipal TuCheng Hospital, Tucheng, New Taipei City, 236, Taiwan.
Internal and emergency medicine
|February 22, 2024
概括
一个新的评分系统显著改善了急性慢性肝衰竭 (ACLF) 患者在ICU的短期死亡预测. 这种新型模型提供了比现有得分更好的预后,有助于及时的肝移植转诊.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 临界护理医学 临界护理医学
- 医学统计 医学统计
背景情况:
- 急性至慢性肝衰竭 (ACLF) 与高短期死亡率有关,需要进入重症监护室 (ICU).
- 准确的预后评估对于ACLF患者及时的肝移植转诊至关重要.
- 现有评分系统的预测效果,如CLIF-C ACLF,在亚洲ICU患者群体中需要进一步调查.
研究的目的:
- 为了比较已建立得分 (MELD,MELD-乳酸盐,CLIF-C ACLF,CLIF-C ACLF-乳酸盐,APACHE-II) 对ACLF患者短期死亡率的预测性能.
- 开发和验证一种新的预后评分系统,用于入住ICU的ACLF患者.
- 评估新模型与现有分数的优越性.
主要方法:
- 对265名连续入住ICU的ACLF肝硬化患者进行了回顾性分析.
- 使用接收器操作特征 (ROC) 分析评估的预测值.
- 一个新的模型开发和内部验证使用五倍交叉验证.
主要成果:
- 现有的评分 (MELD,MELD-乳酸盐,CLIF-C ACLF,CLIF-C ACLF-乳酸盐,APACHE-II) 在预测1个月和3个月死亡率方面表现相似,但不优越.
- 滥用酒精是肝硬化的主要病因.
- 这种新型模型包括年龄,A-a梯度,BUN,总胆红素,INR和HE等级,显示出优异的预测性能 (AUROC为1个月0.863,3个月0.829).
结论:
- 开发的新型ACLF评分系统在预测ICU入院ACLF患者的短期死亡率方面明显优于现有模型.
- 新模型提供了更准确的预后,有可能改善患者管理和移植资格评估.
- 建议进行进一步的外部验证,以确认新型ACLF模型的通用性.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Acute Kidney Injury I: Introduction
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...


